About Ligand

Ligand-owned, Captisol® was invented in 1990 by scientists at the University of Kansas Higuchi Biosciences Center for use in drug development and formulation.

The Captisol® technology is used to address the limitations of currently marketed drugs. FDA-approved, Captisol-enabled® medications are marketed by: Pfizer, Bristol-Myers Squibb and Baxter International. Captisol® also has Licens...

  • US
  • 2017
    On CPHI since
Company types
Contract Service
Contact info
  • 2029 Becker Drive, Suite 217, Lawrence, KS, United States

Products from Ligand (1)

  • Captisol

    Product Captisol

    Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).

Ligand Resources (1)